BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/27/2018 9:38:46 AM | Browse: 984 | Download: 1118
Publication Name World Journal of Hepatology
Manuscript ID 38884
Country/Territory Japan
Received
2018-03-27 09:48
Peer-Review Started
2018-03-27 11:02
To Make the First Decision
2018-04-25 10:13
Return for Revision
2018-04-26 09:34
Revised
2018-07-30 03:45
Second Decision
2018-08-06 09:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-08-07 06:26
Articles in Press
2018-08-07 06:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-09-23 09:58
Publish the Manuscript Online
2018-09-27 09:38
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
Manuscript Source Invited Manuscript
All Author List Issei Saeki, Takahiro Yamasaki, Masaki Maeda, Takuro Hisanaga, Takuya Iwamoto, Koichi Fujisawa, Toshihiko Matsumoto, Isao Hidaka, Yoshio Marumoto, Tsuyoshi Ishikawa, Naoki Yamamoto, Yutaka Suehiro, Taro Takami and Isao Sakaida
ORCID
Author(s) ORCID Number
Issei Saeki http://orcid.org/0000-0001-5885-5042
Takahiro Yamasaki http://orcid.org/0000-0002-9793-0399
Masaki Maeda http://orcid.org/0000-0001-5687-2447
Takuro Hisanaga http://orcid.org/0000-0002-8914-9981
Takuya Iwamoto http://orcid.org/0000-0003-0701-0351
Koichi Fujisawa http://orcid.org/0000-0002-2840-8660
Toshihiko Matsumoto http://orcid.org/0000-0001-6680-7008
Isao Hidaka http://orcid.org/0000-0003-3693-4270
Yoshio Marumoto http://orcid.org/0000-0001-7637-5114
Tsuyoshi Ishikawa http://orcid.org/0000-0003-3722-3083
Naoki Yamamoto http://orcid.org/0000-0001-8423-3634
Yutaka Suehiro http://orcid.org/0000-0002-8822-0053
Taro Takami http://orcid.org/0000-0002-6689-4989
Isao Sakaida http://orcid.org/0000-0002-8365-7547
Funding Agency and Grant Number
Funding Agency Grant Number
the Japan Society for the Promotion of Science, KIBAN-B 05287
Corresponding Author Takahiro Yamasaki, MD, PhD, Professor, Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube 755-8505, Japan. t.yama@yamaguchi-u.ac.jp
Key Words Treatment strategy; Hepatic arterial infusion chemotherapy; Sorafenib; Hepatocellular carcinoma
Core Tip In Japan, sorafenib and hepatic arterial infu­sion chemotherapy (HAIC) are described as treatment options for hepatocellular carcinoma (HCC). Although no randomized controlled trials have compared these treatments, retrospective analyses have shown similar survival between them. Sorafenib is generally used for Child-Pugh A, while HAIC is indicated for Child-Pugh A or B. Compared to sorafenib, HAIC shows better responses in cases exhibiting macroscopic vascular invasion. After reviewing treatment strategies for advanced HCC, we recommended sorafenib as first-line treatment for cases without macroscopic vascular invasion or Child-Pugh A, and HAIC for those with macroscopic vascular invasion or Child-Pugh A or B.
Publish Date 2018-09-27 09:38
Citation Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Fujisawa K, Matsumoto T, Hidaka I, Marumoto Y, Ishikawa T, Yamamoto N, Suehiro Y, Takami T, Sakaida I. Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy. World J Hepatol 2018; 10(9): 571-584
URL http://www.wjgnet.com/1948-5182/full/v10/i9/571.htm
DOI http://dx.doi.org/10.4254/wjh.v10.i9.571
Full Article (PDF) WJH-10-571.pdf
Full Article (Word) WJH-10-571.doc
Manuscript File 38884-Review.docx
Answering Reviewers 38884-Answering reviewers.pdf
Audio Core Tip 38884-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 38884-Conflict-of-interest statement.pdf
Copyright License Agreement 38884-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 38884-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 38884-Language certificate.pdf
Peer-review Report 38884-Peer-review(s).pdf
Scientific Misconduct Check 38884-Scientific misconduct check.pdf
Scientific Editor Work List 38884-Scientific editor work list.pdf